Literature DB >> 25439048

The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).

M L Alva1, A Gray, B Mihaylova, J Leal, R R Holman.   

Abstract

AIMS: To estimate the immediate and long-term inpatient and non-inpatient costs for Type 2 diabetes-related complications.
METHODS: The costs of all consultations, visits, admissions and procedures associated with diabetes-related complications during UK Prospective Diabetes Study post-trial monitoring in the period 1997-2007 were estimated using hospitalization records for 2791 patients in England and resource use questionnaires that were administered to 3589 patients across the UK.
RESULTS: The estimated (95% CI) inpatient care costs (in 2012 pounds sterling) in the event year for the example of a 60-year-old man were: non-fatal ischaemic heart disease £9767 (£7038-£12 696); amputation £9546 (£6416-£13 463); non-fatal stroke £6805 (£3856-£10 278); non-fatal myocardial infarction £6379 (£4290-£8339); fatal stroke £3954 (£2012-£6428); fatal ischaemic heart disease £3766 (£746-£5512); heart failure £3191 (£1678-4903); fatal myocardial infarction £1521 (£647-£2670); and blindness in one eye £1355 (£415-£2655). In subsequent years, estimated (95% CI) costs ranged from £1792 (£1060-£2943) for amputations to £453 (£315-£691) for blindness in one eye. Costs of non-inpatient healthcare in the event year were: amputation £2699 (£1409-£4126); blindness in one eye £1790 (£878-£3056); non-fatal stroke £1019 (£770-£1499); nonfatal myocardial infarction £1963 (£794-£1157); heart failure £979 (£708-£1344); non-fatal ischaemic heart disease £864 (£718-£1014); and cataract extraction £700 (£619-£780). In each subsequent year, non-inpatient costs ranged from £1611 (£1193-£2116) for amputations to £654 (£572-£799) for ischaemic heart disease.
CONCLUSIONS: Diabetic complications are associated with substantial immediate and long-term healthcare costs. Our comprehensive new estimates of these costs, derived from detailed recent UK Prospective Diabetes Study post-trial data, should aid researchers and health policy analyses.
© 2014 The Authors. Diabetic Medicine © 2014 Diabetes UK.

Entities:  

Mesh:

Year:  2015        PMID: 25439048     DOI: 10.1111/dme.12647

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  63 in total

1.  Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting.

Authors:  Melanie J Davies; Divina Glah; Barrie Chubb; Gerasimos Konidaris; Phil McEwan
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981

2.  Predictors for attending annual eye screening for diabetic retinopathy amongst patients with diabetes in an urban community of Beijing.

Authors:  Yan-Hong Zou; Qian Li; Shan-Shan Cui; Wei Jia; Ning Zhang; Kai Ma; Torkel Snellingen; Xi-Pu Liu
Journal:  Int J Ophthalmol       Date:  2017-07-18       Impact factor: 1.779

3.  Evaluating Digital Health Interventions: Key Questions and Approaches.

Authors:  Elizabeth Murray; Eric B Hekler; Gerhard Andersson; Linda M Collins; Aiden Doherty; Chris Hollis; Daniel E Rivera; Robert West; Jeremy C Wyatt
Journal:  Am J Prev Med       Date:  2016-11       Impact factor: 5.043

4.  Health Care Costs Associated With Macrovascular, Microvascular, and Metabolic Complications of Type 2 Diabetes Across Time: Estimates From a Population-Based Cohort of More Than 0.8 Million Individuals With Up to 15 Years of Follow-up.

Authors:  Hsuan-Ying Chen; Shihchen Kuo; Pei-Fang Su; Jin-Shang Wu; Huang-Tz Ou
Journal:  Diabetes Care       Date:  2020-05-22       Impact factor: 19.112

5.  Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

Authors:  Kirsty Winkley; Rebecca Upsher; Daniel Stahl; Daniel Pollard; Architaa Kasera; Alan Brennan; Simon Heller; Khalida Ismail
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

6.  The Effects of Diagnostic Definitions in Claims Data on Healthcare Cost Estimates: Evidence from a Large-Scale Panel Data Analysis of Diabetes Care in Japan.

Authors:  Haruhisa Fukuda; Shunya Ikeda; Takeru Shiroiwa; Takashi Fukuda
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

7.  Economic Value of Improved Accuracy for Self-Monitoring of Blood Glucose Devices for Type 1 and Type 2 Diabetes in England.

Authors:  Robert Brett McQueen; Marc D Breton; Joyce Craig; Hayden Holmes; Melanie D Whittington; Markus A Ott; Jonathan D Campbell
Journal:  J Diabetes Sci Technol       Date:  2018-04-21

8.  [Diagnostic accuracy of dual energy CT angiography in patients with diabetes mellitus].

Authors:  C Schabel; M N Bongers; D Ketelsen; R Syha; C Thomas; G Homann; M Notohamiprodjo; K Nikolaou; F Bamberg
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

9.  Trajectory of Excess Medical Expenditures 10 Years Before and After Diabetes Diagnosis Among U.S. Adults Aged 25-64 Years, 2001-2013.

Authors:  Sundar S Shrestha; Ping Zhang; Israel A Hora; Edward W Gregg
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

10.  Budget Impact of Improved Diabetes Management by Utilization of Glucose Meters With a Color-Range Indicator-Comparison of Five European Healthcare Systems.

Authors:  Katharina Fritzen; Kornelia Basinska; Constantin Stautner; Karl F Braun; Matilde Rubio-Almanza; Antonio Nicolucci; Brian Kennon; Bruno Vergès; Yasser Hosny; Oliver Schnell
Journal:  J Diabetes Sci Technol       Date:  2019-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.